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Abstract
Background: Surgery followed by chemotherapy is the primary modality of cure for patients with
resectable pancreatic cancer but is associated with significant morbidity. The aim of the present study
was to evaluate the role of cardiopulmonary exercise testing (CPET) in predicting post-operative adverse
events and fitness for chemotherapy after major pancreatic surgery.
Methods: Patients who underwent a pancreaticoduodenectomy or total pancreatectomy for pancreatic
head lesions and had undergone pre-operative CPET were included in this retrospective study. Data on
patient demographics, comorbidity and results of pre-operative evaluation were collected. Post-operative
adverse events, hospital stay and receipt of adjuvant therapy were outcome measures.
Results: One hundred patients were included. Patients with an anaerobic threshold less than 10 ml/kg/
min had a significantly greater incidence of a post-operative pancreatic fistula [International Study Group
for Pancreatic Surgery (ISGPS) Grades A–C, 35.4% versus 16%, P = 0.028] and major intra-abdominal
abscesses [Clavien–Dindo (CD) Grades III–V, 22.4% versus 7.8%, P = 0.042] and were less likely to
receive adjuvant therapy [hazard ratio (HR) 6.30, 95% confidence interval (CI) 1.25–31.75, P = 0.026]. A
low anaerobic threshold was also associated with a prolonged hospital stay (median 20 versus 14 days,
P = 0.005) but not with other adverse events.
Discussion: CPET predicts a post-operative pancreatic fistula, major intra-abdominal abscesses as well
as length of hospital stay after major pancreatic surgery. Patients with a low anaerobic threshold are less
likely to receive adjuvant therapy.
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Introduction
Pancreatic cancer is the 10th most common cancer in the UK but
the fifth most common cause of cancer death with only 16–17%
surviving beyond the first year and 3% surviving beyond 5 years.1
The majority of patients (80–85%) with pancreatic cancer present
with inoperable disease.1,2 In patients with resectable disease,
surgery2–4 followed by adjuvant chemotherapy5,6 remains the
primary modality of cure.
The decision to operate on these patients depends not only on
the pre-operative tumour stage but also on patient factors.7,8
Patient factors, in particular those that affect fitness, are also
important in determining the short-term outcome in those that
do undergo potentially curative surgery.9,10 However, major pan-
creatic surgery is associated with significant morbidity and mor-
tality and patients who have post-operative complications are less
likely to get adjuvant therapy.11
There have been a number of attempts to objectively define
patient fitness and its relationship with post-operative outcome.
Copeland et al. (1991) reported that the Physiological and Opera-
tive Severity Score for the enumeration of Mortality and Morbid-
ity (POSSUM) criteria, in particular the POSSUM physiology
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score (PPS) could be used to quantify the risk of post-operative
morbidity and mortality.12 However, the role of POSSUM in pre-
dicting post-operative outcome after surgery for pancreatic cancer
is not entirely clear.13–17 The physiological component of POSSUM
as well as other similar risk scoring systems such as E-PASS (Esti-
mation of Physiologic Ability and Surgical Stress)18 are calculated
based on known comorbidities, clinically evident abnormalities in
patient physiology or blood tests.
More recently, there has been some evidence that the presence
of an ongoing systemic inflammatory response before surgery is
associated with the development of post-operative complications
in patients undergoing surgery for colorectal cancer,19 oesopha-
geal cancer20 as well as pancreatic cancer.21
Older et al. (1993) reported that cardiopulmonary exercise
testing (CPET) was an objective evaluation of the response of the
cardiovascular and respiratory systems to an increase in oxygen
demand during exercise and was useful in predicting peri-
operative morbidity and mortality in patients undergoing major
abdominal surgery.22
The aim of the present study was to evaluate the role of various
measures of patient physiological fitness including cardiopulmo-
nary exercise testing in predicting post-operative adverse events as
well as fitness for adjuvant therapy in patients undergoing major
pancreatic surgery.
Methods
Patients who underwent a pancreaticoduodenectomy or total
pancreatectomy for pancreatic head lesions between August 2008,
when cardiopulmonary exercise testing was first used for fitness
assessment at our hospital, and January 2012 were considered for
this retrospective study. Patients who had not undergone cardiop-
ulmonary exercise testing as part of their preoperative assessment
and patients who underwent cardiopulmonary exercise testing
but did not undergo surgery were excluded.
Data on patient demographics, comorbidity including cardio-
vascular and respiratory disease, pre-operative blood tests, chest
X-ray and cardiopulmonary exercise tests were collected from
prospectively maintained databases (March 2009–January 2012)
and case note review (August 2008–March 2009). Data were also
collected for patients who did not undergo cardiopulmonary exer-
cise testing to allow comparison with the study group. The
POSSUMPhysiology Score was calculated based on 11 physiologi-
cal parameters [cardiac disease including hypertension, ischaemic
heart disease and heart failure, respiratory disease causing breath-
lessness on exertion and chronic obstructive pulmonary disease
(COPD), electrocardiography (ECG) changes, pulse rate, blood
pressure, haemoglobin, white cell count, serum sodium, serum
potassium, serum urea and Glasgow Coma Scale] as described
previously.
Cardiopulmonary exercise tests were performed in the Depart-
ment of Respiratory Medicine at the Glasgow Royal Infirmary
using the ZAN-600 CPET suite (nSpire Health, Longmont, CO,
USA). An electrically-braked cycle ergometer was used to perform
a symptom-limited, incremental work-load test preceded by a
3-min rest period. The test was stopped at maximum exercise
tolerance, significant ischaemic changes on ECG or for other
safety reasons. The anaerobic threshold was calculated using the
V-slope23,24 and ventilatory equivalents23 methods. A low anaero-
bic threshold was defined as oxygen consumption less than 10 ml/
kg/min based on previous work by Snowden et al.25 who reported
that an anaerobic threshold less than 10.1 ml/kg/min was associ-
ated with an increase in post-operative complications after major
abdominal surgery.
The decision to operate was based on overall pre-operative
evaluation of the patient’s comorbid conditions and performance
status and not exclusively on the result of cardiopulmonary exer-
cise testing. While the results of cardiopulmonary exercise tests
were available to the clinicians before surgery, no specific changes
were made to peri-operative management based exclusively on
these results. These results were used in conjunction with other
established forms of pre-operative evaluation for risk assessment
and peri-operative care. All patients were routinely admitted to
the surgical high-dependency unit unless intra-operative events or
post-operative complications required admission to the intensive
care unit. Patients were discharged after resolution of organ dys-
function and/or sepsis and when nutrition, analgesia and mobili-
zation were adequately established to the clinician’s and patient’s
satisfaction.
Post-operative adverse events were recorded using internation-
ally recognized definitions. The International Study Group for
Pancreatic Surgery (ISGPS) definitions were used to classify pan-
creatic fistulae26 and post-operative haemorrhage.27 The Clavien–
Dindo (CD) classification28,29 was used to grade other
complications and CD grades III–V were considered major. Mul-
tiple admissions to critical care as well as re-operations were
recorded. Operative mortality was defined as post-operative death
in-hospital regardless of duration of stay or occurring within 30
days of the surgery. All complications were discussed at a weekly
multidisciplinary meeting attended by three pancreatic surgeons
and a radiologist with a specialist interest in pancreatic diseases
and recorded in a prospective database.
Primary outcome measures were length of stay in hospital,
major post-operative adverse events including operative mortality
and fitness to undergo adjuvant therapy when indicated. Second-
ary outcome measures included cumulative length of stay in criti-
cal care and the number of critical care admissions.
Statistical analysis
Grouping of the variables was carried out using standard or previ-
ously published thresholds. In the absence of such thresholds, the
variables were treated as continuous variables and analysed using
non-parametric statistical methods. Cox proportional hazards
regression analysis was used to study the relationship between pre-
operative risk factors and length of hospital stay. The chi-square test
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was used to examine the relationship between complications and
anaerobic threshold as a categorical variable. Univariate binary
logistic regression analysis with a calculation of hazard ratios (HR)
and 95% confidence intervals (CIs) was used to explore the asso-
ciation between peri-operative clinico-pathological factors and
receipt of adjuvant therapy. Multivariate binary logistic regression
analysis was performed on all variables showing a significant asso-
ciation on univariate analysis. Backward stepwise regression was
used starting with a saturated model and variables with P-value >
0.1 were excluded at each step until no more variables could be
excluded. SPSS software (Version 17.0; SPSS Inc., Chicago, IL,USA)
was used to perform statistical analysis.
Results
One hundred and twenty-nine patients had undergone a pancrea-
ticoduodenectomy (n = 127), sub-total pancreatectomy (n = 1) or
total pancreatectomy (n = 1) during the study period. Sub-total
and total pancreatectomies were performed in patients scheduled
for a pancreaticoduodenectomy but were found to have pancreatic
remnants either too friable or too atrophic during the operation
to perform an anastomosis. Of these, 100 patients (pancreati-
coduodenectomy, 98 and sub-total/total pancreatectomy, 2) had
undergone cardiopulmonary exercise testing as part of their pre-
operative assessment and were included in the study. Pathological
Table 1 Clinico-pathological characteristics of patients undergoing major pancreatic surgery during the study period
All patients Excluded Included P
n = 129 n = 29 n = 100
Age (years)
65 71 (55%) 24 47 0.001
>65 58 (45%) 5 53
Gender
Male 77 (60%) 17 60 0.894
Female 52 (40%) 12 40
BMI (kg/m2)
25 53 (44%) 8 45 0.817
>25 66 (56%) 11 55
Pre-operative biliary drainage
No 68 (59%) 12 56 0.154
Yes 48 (41%) 4 44
mGPS
0 76 (59%) 13 63 0.279
1 11 (9%) 5 6
2 41 (32.0%) 10 31
Haemoglobin (g/dl)
12 80 (64%) 18 62 0.353
<12 45 (36%) 7 38
POSSUM Physiology Score
11–14 61 (51%) 12 50 0.701
>14 59 (49%) 10 50
Serum bilirubin (micromol/l)
35 70 (55%) 12 58 0.156
>35 58 (45%) 16 42
Operation type
Pancreatico-duodenectomy 127 (98%) 29 98 0.045
(Sub-)Total Pancreatectomy 2 (2%) 0 2
Operative mortality 7 (5%) 0 7 0.144
Postoperative stay (days) 17 (13–27) 20 (13–30) 17 (13–26) 0.518
Critical care stay (days) 7 (6–12) 7 (6–14) 7 (6–12) 0.448
Values are either median (inter-quartile range) with P statistic using the Mann–Whitney test or number of patients (percentage) with P statistic using
the chi-square test.
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examination of the resected specimen showed pancreatic ductal
adenocarcinoma (n = 37), ampullary adenocarcinoma (n = 18),
cholangiocarcinoma (n = 17), duodenal adenocarcinoma (n = 6),
intraductal papillary mucinous neoplasia (n = 4), neuroendocrine
tumours (n = 7), other neoplasia (n = 4) or chronic pancreatitis
(n = 2).
Twenty-nine patients did not undergo cardiopulmonary exer-
cise testing owing to reasons including subjective assessment of
fitness, resource constraints and logistics. Table 1 shows the
clinico-pathological characteristics of patients included in the
study compared with the excluded patients. The median age in
the study cohort was higher than in the excluded cohort (66 versus
54 years, P = 0.001). However, there was no difference in gender,
body mass index, pre-operative biliary drainage, jaundice at the
time of surgery, modified Glasgow Prognostic Score, POSSUM
physiology score, pre-operative blood tests including haemoglobin
and liver function tests and length of critical care/hospital stay. The
overall post-operative mortality during the study period was 5.4%
(7/129) with all deaths occurring in the study cohort (P = 0.144).
The median anaerobic threshold was 10.3 ml/kg/min (inter-
quartile range, IQR 8.8–11.6). The anaerobic threshold was less
than 10 ml/kg/min in 49 patients. The distribution of anaerobic
threshold across the study cohort is shown in Fig. 1.
The relationship between anaerobic threshold and major post-
operative adverse events including mortality is shown in Table 2.
Patients with an anaerobic threshold less than 10 ml/kg/min had a
significantly greater incidence of post-operative pancreatic fistula
(35.4% versus 16%, P = 0.028) as well as major intra-abdominal
abscesses (CD Grade III–V, 22.4% versus 7.8%, P = 0.042). While
there was an association between low anaerobic threshold and grade
of pancreatic fistula, this was not statistically significant (P = 0.091).
There was no association between low anaerobic threshold and
cardiopulmonary complications or post-operative mortality.
Major cardiopulmonary complications occurred more often in
patients with major intra-abdominal adverse events including
major intra-abdominal abscesses or Grade B and C pancreatic
fistulae or haemorrhage than in patients who did not have these
complications (5/31, 16.1% versus 2/69, 2.9%, P = 0.017). Post-
operative mortality was not associated with anaerobic threshold
(HR 0.77, 95% CI 0.16–3.61, p 0.737) or the POSSUM Physiology
Score (HR 0.39, 95% CI 0.07–2.12, P = 0.277). Post-operative
mortality was associated with post-operative pancreatic fistula
(n = 5), post-pancreatectomy haemorrhage (n = 3), major intra-
abdominal sepsis (n = 6) and major cardiorespiratory complica-
tions (n = 4) with six patients requiring radiological or operative
intervention.
The median length of post-operative stay was 17 days (IQR
13–26). The median cumulative length of stay in critical care was
7 days (IQR 6–12). Twenty-six patients were admitted to critical
care more than once. The relationship between pre-operative
clinico-pathological characteristics and length of post-operative
stay in patients who were discharged from hospital (n = 93) is
shown in Table 3. On univariate analysis, age over 65 years (P =
0.072) and low anaerobic threshold (P = 0.010) were associated
with prolonged post-operative stay. On multivariate Cox propor-
tional hazards regression analysis, an anaerobic threshold less than
10 ml/kg/min (hazard ratio 1.74, 95% CIs 1.14–2.65, P = 0.010)
was the only significant factor associated with prolonged post-
operative stay. A Kaplan–Meier plot for the probability of remain-
ing in hospital over time for patients with low and normal
anaerobic thresholds is shown in Fig. 2. Patients with a low
anaerobic threshold stayed a median 6 days longer in hospital (14
versus 20 days, Mann–Whitney U-test P = 0.001). There was no
significant association between any of the pre-operative factors
including anaerobic threshold and length of critical care stay or
number of critical care admissions.
The relationship between clinico-pathological patient factors
and receipt of adjuvant therapy is shown in Table 4. Fifty-five
patients were included in the analysis. Patients were excluded if
chemotherapy was not indicated (n = 28), in the event of operative
mortality (n = 7), if chemotherapy was offered but declined by the
patient (n = 4), or where they had not been seen by an oncologist
yet (n = 6). On binary logistic regression analysis, an anaerobic
threshold less than 10 ml/kg/min was the only pre-operative
factor that was associated with non-receipt of adjuvant therapy
(HR 6.30, 95% CI 1.25–31.75, P = 0.026).
Discussion
The results of the present study show that a low anaerobic
threshold is associated with prolonged post-operative stay in
hospital, post-operative pancreatic fistula and intra-abdominal
abscesses in patients undergoing major resections for pancreatic
head lesions. The results of this study also show that patients
with a low anaerobic threshold are less likely to receive adjuvant
therapy.
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Figure 1 Distribution of anaerobic threshold across the study
population
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Therefore, it would appear that objective measurement of
patient physiological fitness using cardiopulmonary exercise
testing is superior to conventional measures of patient fitness
including the POSSUMPhysiology Score or themodified Glasgow
Prognostic Score and may have a role in predicting short-term
outcome which in turn affects the overall management of these
patients including receipt of adjuvant therapy.
Patients with a low anaerobic threshold stayed longer in hospi-
tal after their operation. While length of stay in hospital is influ-
enced by multiple factors including post-operative complications,
it would appear that patients with a low anaerobic threshold take
longer to recover from the physiological stress placed by major
pancreatic surgery and its sequelae.
The incidence of a pancreatic fistula was greater in patients
with a low anaerobic threshold. This association needs further
evaluation taking into consideration other well-recognised risk
factors for pancreatic fistula such as pancreatic texture, pancre-
atic duct size and intra-operative blood loss.30–32 It is possible
that local or operative factors may be compounded by poor
oxygen delivery and organ perfusion as measured by cardiopul-
monary exercise testing. There was a non-significant trend
towards clinically relevant pancreatic fistulae (ISGPS Grades B
and C) as well as a significant association with major intra-
abdominal abscesses (CD Grades 3–5, i.e. requiring intervention,
associated with organ dysfunction requiring intensive care or
resulting in mortality). This would suggest that complications in
Table 2 The relationship between the anaerobic threshold and complications in patients undergoing major pancreatic surgery
Anaerobic threshold (ml/kg/min)
Complications 10 <10 P
n n
Cardiac complications
Grade 0–II 99 51 48 0.308
Grade III–V 1 0 1
Respiratory complications
Grade 0–II 93 48 45 0.657
Grade III–V 7 3 4
Intra-abdominal abscess
Grade 0–II 85 47 38 0.042
Grade III–V 15 4 11
Pancreatic fistula (total/sub-total pancreatectomies excluded)
No 73 42 31 0.028
Yes 25 8 17
Pancreatic fistula (ISGPS Classification)
No 73 42 31 0.091
Grade A 9 3 6
Grade B 8 1 7
Grade C 8 4 4
Post-pancreatectomy haemorrhage (ISGPS Classification)
No 84 41 43 0.207
Grade A 4 2 2
Grade B 4 2 2
Grade C 8 6 2
Admissions to critical care
1 74 38 36 0.906
>1 26 13 13
Re-operation
No 89 47 42 0.306
Yes 11 4 7
Operative mortality
No 93 47 46 0.737
Yes 7 4 3
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patients with a low anaerobic threshold are more likely to be
severe than in patients with normal anaerobic threshold.
However, there was no difference in mortality between patients
with a normal or low anaerobic threshold, indicating that mul-
tiple factors including pre-operative patient fitness, local and
operative factors, systemic inflammatory response, number of
complications as well as peri-operative critical care all play a
role.
The results of this study also show that patients with a low
anaerobic threshold were less likely to receive adjuvant therapy.
Adjuvant therapy in patients undergoing pancreatic resections for
cancer has been shown in multiple randomized trials to improve
survival significantly.5,6 While post-operative mortality after pan-
creatic surgery has steadily improved over the years with major
improvements in the quality of surgical and critical care over the
past decade31 even in elderly patients,33 post-operative morbidity
remains high.10 The results of this study show that poor pre-
operative fitnees is not only associated with a protracted pro-
tracted post-operative course with complications but also with
non-receipt of adjuvant therapy.
Table 3 The relationship between clinico-pathological characteristics and post-operative stay in patients (excluding operative mortality)
undergoing major pancreatic surgery (n = 93): Cox's regression analysis
Univariate Multivariate
Variable n HR 95% CI P HR 95% CI P
Age (years)
65 44
>65 49 1.47 0.97–2.24 0.072 1.48 0.97–2.25 0.068
Gender
Male 56
Female 37 1.32 0.86–2.03 0.199
BMI (kg/m2)
25 42
>25 51 0.87 0.58–1.32 0.512
Smoking
No 56
Yes 37 1.26 0.82–1.94 0.294
POSSUM Physiology Score
14 45
>14 48 1.28 0.85–1.95 0.240
Pre-operative biliary drainage
No 53
Yes 40 1.08 0.71–1.65 0.724
Serum bilirubin (micromol/l)
35 54
>35 39 1.26 0.83–1.92 0.277
mGPS
0 59
1 5 1.22 0.78–1.92 0.387
2 29 1.87 0.71–4.88 0.204
Haemoglobin (g/dl)
12 57
<12 36 1.19 0.78–1.81 0.422
Anaerobic threshold (ml/kg/min)
10 47
<10 46 1.74 1.14–2.64 0.010 1.74 1.14–2.65 0.010
Anaerobic threshold (ml/kg/min)
11 33
<11 60 1.44 0.94–2.22 0.097 0.395
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In the present study, the anaerobic threshold was less than
10 ml/kg/min in 49% of patients and less than 11 ml/kg/min in
64% of patients. The proportion of patients with an anaerobic
threshold less than 11 ml/kg/min in this study was much greater
than reported in studies involving patients undergoing oesopha-
geal surgery (16%),34 liver transplantation (39%)35 or other major
abdominal surgery (29%)22 and may indicate the poor pre-
operative fitness levels of patients undergoing major pancreatic
surgery at our unit. While several previous studies have shown
that low anaerobic threshold and/or low VO2 peak are associated
with post-operative complications or prolonged hospital stay after
major abdominal surgery as well as non-abdominal surgery,22,35–39
others have disputed this.34,40,41 Older et al. reported in 1993 that a
low anaerobic threshold less than 11 ml/kg/min was associated
with a significantly higher risk of postoperative mortality from
cardiovascular causes in a series of 187 elderly patients undergo-
ing major abdominal surgery.22 However, Snowden et al.25
reported that patients with an anaerobic threshold less than
10.1 ml/kg/min had significantly greater cardiopulmonary com-
plications as well as non-cardiopulmonary and infectious compli-
cations whereas Forshaw et al.34 reported that using a cut-off of
11 ml/kg/min for the anaerobic threshold did not predict post-
operative adverse events less after an oesophagectomy. The lack of
an association between a low anaerobic threshold and cardiopul-
monary complications in this study may have been due to two
reasons. Major cardiopulmonary complications occurred more
often in association with major intra-abdominal adverse events
which are determined largely by pancreatic morphology and local
anatomy.30 Moreover, the stringent fitness criteria for undergoing
a pancreaticoduodenectomy may have excluded patients with
known co-morbid cardiorespiratory diseases such as severe
chronic obstructive pulmonary disease or cardiac failure.
The results of this study are consistent with the results of the
previous study by Ausania et al.42 who reported an increased inci-
dence of pancreatic fistula and prolonged post-operative stay in
patients with an anaerobic threshold less than 10.1 ml/kg/min.
However, this study did not report the association between
anaerobic threshold and receipt of adjuvant therapy.
The physiological demands placed on a patient undergoing
major pancreatic surgery are significant, both during and after the
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Figure 2 Kaplan–Meier Plot of post-operative length of stay in
patients with an anaerobic threshold 10 ml/kg/min compared with
<10 ml/kg/min
Table 4 The relationship between clinico-pathological characteris-
tics and receipt of adjuvant therapy in patients undergoing major
pancreatic surgery (n = 55): binary logistic regression
Univariate
Variable n = 55 HR 95% CI P
Age (years)
65 25
>65 30 2.63 0.71–9.74 0.149
Gender
Male 31
Female 24 2.08 0.61–7.13 0.242
BMI (kg/m2)
25 25
>25 30 0.78 0.23–2.64 0.693
Smoking
No 35
Yes 20 0.96 0.27–3.41 0.953
POSSUM physiology score
14 25
>14 30 1.63 0.46–5.73 0.447
Pre-operative biliary drainage
No 27
Yes 28 0.95 0.28–3.21 0.937
Serum bilirubin (micromol/l)
35 27
>35 28 2.08 0.60–7.30 0.251
mGPS
0 32
1 2 0.0 0.0
2 21 1.20 0.35–4.15 0.773
Haemoglobin (g/dl)
12 31
<12 24 0.96 0.28–3.26 0.946
Anaerobic threshold (ml/kg/min)
10 23
<10 32 6.30 1.25–31.75 0.026
Anaerobic threshold (ml/kg/min)
11 16
<11 39 3.11 0.61–15.88 0.172
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operation. It is not entirely surprising therefore, that conventional
parameters of patient fitness such as the POSSUM Physiology
Score or the modified Glasgow Prognostic Score are limited in
their ability to distinguish patients based on their performance
under physiological stress. Cardiopulmonary exercise testing
overcomes this disadvantage by replicating some of the physi-
ological burden major pancreatic surgery places on the functional
capacity of the patient’s cardiovascular and respiratory systems.
This functional capacity of patients to withstand the physi-
ological burden of major surgery can be improved by the process
of ‘prehabilitation’.43 It has been suggested that prehabilitation not
only improves aerobic capacity44 but may also improve post-
operative recovery.45,46 The results of this study show that impaired
aerobic capacity is associated with post-operative adverse events.
Therefore, it would appear that prehabilitation using interven-
tions such as exercise and nutrition, by improving physiological
fitness, may have a role in improving post-operative outcomes
after major pancreatic surgery andmay improve the proportion of
patients receiving adjuvant therapy.
Further work needs to be carried out to study the value of
cardiopulmonary exercise testing in predicting post-operative
complications in conjunction with previously established factors
such as pancreatic morphology and operative factors before it can
be used on its own to select or exclude patients for a pancreati-
coduodenectomy. Cardiopulmonary exercise testing would play
an important role not only in identifying patients who will benefit
from prehabilitation, but also in the objective measurement of the
effects of such interventions on aerobic capacity as well as in
identifying high-risk patients who may not be able to complete
oncological treatment. Prehabilitation and optimized peri-
operative care may allow a greater proportion of high-risk
patients to progress to oncological treatment after surgery.
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